🔗 Share this article Individuals Coming Off Anti-Obesity Medications Regain Weight Four Times Faster Than Dieters Obesity treatment involves ongoing approaches. A recent study reveals that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise regimens. Published data in a leading medical journal shows that while obese people often shed substantial amounts of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month upon discontinuation. "People buying such medications should be aware of the risk of rapid weight regain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb. That rate of regain means a reversion to starting mass in about a year and a half. Comparing Treatments The analysis, which looked at 37 of studies involving thousands of patients, compared the results of the injectable medications with other pills. The team point out that individuals who shed pounds through lifestyle changes alone usually see a more gradual weight regain—perhaps 0.1 kg a month—once they finish. Understanding the Quick Regain Doctors believe the way of the injections is key to understanding the accelerated regain. These medications imitate a natural hormone called glucagon-like peptide-1, which moderates appetite. "Artificially providing the hormone concentrations several times higher than the body's typical production might result in the system to produce less of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert. "Withdrawal of this hormone supplement means appetite is unsuppressed, making excessive eating a significant risk." An Ongoing Issue? Medical guidelines suggest the jabs for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications. Many experts say that, considering the likelihood of relapse, the treatment might need to be long-term. This perspective is echoed by pharmaceutical companies, who say that the results "underscore the persistent character of obesity," akin to managing conditions like hypertension. User Testimonies People who have come off the medication report a powerful resurgence of appetite. "It was like something flipping and you're instantly extremely hungry," described a patient. This challenge is exacerbated if individuals have not established lasting dietary or behavioural changes during therapy. Growing Interest Recent estimates show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial. Use is greater among women compared to males. The 40s and 50s age group shows the highest usage rates. Many access the drugs through private healthcare rather than the NHS. Finally, experts emphasize that while these medications are potent agents for weight loss, they are not a permanent fix and long-term success hinges on ongoing behavioural management.
Obesity treatment involves ongoing approaches. A recent study reveals that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise regimens. Published data in a leading medical journal shows that while obese people often shed substantial amounts of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month upon discontinuation. "People buying such medications should be aware of the risk of rapid weight regain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb. That rate of regain means a reversion to starting mass in about a year and a half. Comparing Treatments The analysis, which looked at 37 of studies involving thousands of patients, compared the results of the injectable medications with other pills. The team point out that individuals who shed pounds through lifestyle changes alone usually see a more gradual weight regain—perhaps 0.1 kg a month—once they finish. Understanding the Quick Regain Doctors believe the way of the injections is key to understanding the accelerated regain. These medications imitate a natural hormone called glucagon-like peptide-1, which moderates appetite. "Artificially providing the hormone concentrations several times higher than the body's typical production might result in the system to produce less of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert. "Withdrawal of this hormone supplement means appetite is unsuppressed, making excessive eating a significant risk." An Ongoing Issue? Medical guidelines suggest the jabs for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications. Many experts say that, considering the likelihood of relapse, the treatment might need to be long-term. This perspective is echoed by pharmaceutical companies, who say that the results "underscore the persistent character of obesity," akin to managing conditions like hypertension. User Testimonies People who have come off the medication report a powerful resurgence of appetite. "It was like something flipping and you're instantly extremely hungry," described a patient. This challenge is exacerbated if individuals have not established lasting dietary or behavioural changes during therapy. Growing Interest Recent estimates show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial. Use is greater among women compared to males. The 40s and 50s age group shows the highest usage rates. Many access the drugs through private healthcare rather than the NHS. Finally, experts emphasize that while these medications are potent agents for weight loss, they are not a permanent fix and long-term success hinges on ongoing behavioural management.